Vir (VIR), Glaxo's Xevudy Wins EC Approval for COVID-19

Published on December 20, 2021

Vir Biotechnology, Inc. (VIR) and partner GlaxoSmithKline obtain the European Commission's nod for Xevudy for the early treatment of COVID-19.

Continue reading on website
Other news

Accuray's (ARAY) CyberKnife System Gets Shonin Approval

December 20, 2021
Accuray's (ARAY) CyberKnife System can now be marketed in Japan post the Shonin approval.

Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now

December 20, 2021
PerkinElmer (PKI) continues to gain momentum from a solid product portfolio and healthy margins. However, forex woes linger.